Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Paul

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Trials|April 15, 2021
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network responseLaura Robison, Yeoungjee Cho, Andrea K Viecelli, et al.
Kidney360|April 4, 2022
Predictors of Arteriovenous Fistula Failure: A <i>Post Hoc</i> Analysis of the FAVOURED StudyYong Pey See, Yeoungjee Cho, Elaine M Pascoe, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.
Journal of the American Society of Nephrology : JASN|December 26, 2023
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney TransplantFlavio Vincenti, Oriol Bestard, Amarpali Brar, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 19, 2026
Patient and nurse trainer perspectives on a structured PD training programme: A process evaluation of the TEACH-PD feasibility trialKarine E Manera, Allison Jaure, David W Johnson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 29, 2021
Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysisMark K Tiong, Rathika Krishnasamy, Edward R Smith, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Nephrology (Carlton, Vic.)|July 25, 2015
Baseline characteristics of the omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) studyAndrea K Viecelli, Elaine M Pascoe, Kevan R Polkinghorne, et al.
Plos One|March 27, 2019
Fish oil and aspirin effects on arteriovenous fistula function: Secondary outcomes of the randomised omega-3 fatty acids (Fish oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) trialAndrea K Viecelli, Kevan R Polkinghorne, Elaine M Pascoe, et al.
Trials|April 15, 2021
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network responseLaura Robison, Yeoungjee Cho, Andrea K Viecelli, et al.
Kidney360|April 4, 2022
Predictors of Arteriovenous Fistula Failure: A <i>Post Hoc</i> Analysis of the FAVOURED StudyYong Pey See, Yeoungjee Cho, Elaine M Pascoe, et al.
Blood|October 5, 2011
Phase 2 trial of clofarabine in combination with etoposide and cyclophosphamide in pediatric patients with refractory or relapsed acute lymphoblastic leukemiaNobuko Hijiya, Blythe Thomson, Michael S Isakoff, et al.
Blood Purification|January 23, 2020
A tRial Evaluating Mid Cut-Off Value Membrane Clearance of Albumin and Light Chains in HemoDialysis Patients: A Safety Device StudyRathika Krishnasamy, Carmel M Hawley, Meg J Jardine, et al.
Journal of the American Society of Nephrology : JASN|December 26, 2023
Isatuximab Monotherapy for Desensitization in Highly Sensitized Patients Awaiting Kidney TransplantFlavio Vincenti, Oriol Bestard, Amarpali Brar, et al.
The Journal of Vascular Access|June 10, 2022
A comparison of arteriovenous fistula failure between Malaysian and Australian and New Zealand participants enrolled in the FAVOURED trialRebecca Hudson, Elaine M Pascoe, Yong Pey See, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 19, 2026
Patient and nurse trainer perspectives on a structured PD training programme: A process evaluation of the TEACH-PD feasibility trialKarine E Manera, Allison Jaure, David W Johnson, et al.
Hemodialysis International. International Symposium on Home Hemodialysis|March 29, 2021
Effect of a medium cut-off dialyzer on protein-bound uremic toxins and mineral metabolism markers in patients on hemodialysisMark K Tiong, Rathika Krishnasamy, Edward R Smith, et al.
Pageof 4